WELL

195.97

-0.73%↓

PLD

131.37

-0.25%↓

EQIX

971.55

+1.34%↑

AMT

173.35

-0.3%↓

SPG

181.25

-1.79%↓

WELL

195.97

-0.73%↓

PLD

131.37

-0.25%↓

EQIX

971.55

+1.34%↑

AMT

173.35

-0.3%↓

SPG

181.25

-1.79%↓

WELL

195.97

-0.73%↓

PLD

131.37

-0.25%↓

EQIX

971.55

+1.34%↑

AMT

173.35

-0.3%↓

SPG

181.25

-1.79%↓

WELL

195.97

-0.73%↓

PLD

131.37

-0.25%↓

EQIX

971.55

+1.34%↑

AMT

173.35

-0.3%↓

SPG

181.25

-1.79%↓

WELL

195.97

-0.73%↓

PLD

131.37

-0.25%↓

EQIX

971.55

+1.34%↑

AMT

173.35

-0.3%↓

SPG

181.25

-1.79%↓

Search

CubeSmart

Avatud

SektorKinnisvara

36.77 -1.76

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

36.44

Max

37.74

Põhinäitajad

By Trading Economics

Sissetulek

-5.2M

78M

Müük

-2.4M

283M

P/E

Sektori keskmine

26.61

67.236

Aktsiakasum

0.34

Dividenditootlus

5.41

Kasumimarginaal

27.494

Töötajad

3,121

EBITDA

-6.7M

173M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+16.05% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

5.41%

6.64%

Järgmine tulemuste avaldamine

30. apr 2026

Järgmine dividendimakse kuupäev

15. apr 2026

Järgmine aktsia dividendi kuupäev (ex-date)

1. apr 2026

Turustatistika

By TradingEconomics

Turukapital

-186M

8.9B

Eelmine avamishind

38.53

Eelmine sulgemishind

36.77

Uudiste sentiment

By Acuity

62%

38%

130 / 167 Pingereas Real estate

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

CubeSmart Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. märts 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23. märts 2026, 22:55 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23. märts 2026, 21:51 UTC

Omandamised, ülevõtmised, äriostud

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23. märts 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23. märts 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23. märts 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23. märts 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23. märts 2026, 22:42 UTC

Market Talk
Uudisväärsed sündmused

Global Equities Roundup: Market Talk

23. märts 2026, 22:42 UTC

Market Talk
Uudisväärsed sündmused

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23. märts 2026, 22:40 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23. märts 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23. märts 2026, 22:22 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23. märts 2026, 22:18 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23. märts 2026, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23. märts 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23. märts 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. märts 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23. märts 2026, 21:10 UTC

Uudisväärsed sündmused

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23. märts 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk
Tulu
Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

CubeSmart Prognoos

Hinnasiht

By TipRanks

16.05% tõus

12 kuu keskmine prognoos

Keskmine 42.58 USD  16.05%

Kõrge 48 USD

Madal 37 USD

Põhineb 14 Wall Streeti analüütiku instrumendi CubeSmart 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

6

Osta

8

Hoia

0

Müü

Tehniline skoor

By Trading Central

41.915 / 43.08Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

130 / 167 Pingereas Kinnisvara

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest CubeSmart

CubeSmart is a self-administered and self-managed real estate investment trust. The Company's self-storage properties are designed to offer affordable, easily accessible and, in most locations, climate-controlled storage space for residential and commercial customers. According to the 2024 Self-Storage Almanac, CubeSmart is one of the top three owners and operators of self-storage properties in the United States.
help-icon Live chat